Cambridge Antibody Technology Group plc

Cambridge Antibody Technology (CAT) is a UK biotechnology company. CAT is using its proprietary technologies in fully human monoclonal antibodies for drug discovery and drug development. CAT's world-leading platform technology forms the basis for the Company's strategy: to develop a portfolio of clinical development programmes and to aid the discovery of new drugs using functional genomics. Business Strategy: CAT's strategy is underpinned by its technology. CAT will secure short and long term revenues through technology access and product development respectively. CAT will work in partnership with others at all stages of the discovery and development process.

Activity:

Product / Technology type(s) covered:

- Bio
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: